Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iterum Therapeutics Plc (NQ: ITRM ) 1.050 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Iterum Therapeutics Plc < Previous 1 2 3 4 5 6 7 8 Next > ITRM ALERT: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action Lawsuit August 06, 2021 From Robbins Geller Rudman & Dowd LLP Via Business Wire SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm August 06, 2021 From The Schall Law Firm Via Business Wire ITRM INVESTOR ALERT: Rosen Law Firm Encourages Iterum Therapeutics plc Investors with Losses Over $100K to Secure Counsel Before Important Deadline – ITRM August 06, 2021 From The Rosen Law Firm, P.A. Via Business Wire Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates August 02, 2021 The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi... Via Benzinga 63 Biggest Movers From Friday August 02, 2021 Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the... Via Benzinga Exposures Product Safety 41 Stocks Moving In Friday's Mid-Day Session July 30, 2021 Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares jumped 90.6% to $7.84 after the company said the FDA has granted its eryaspase fast track designation for the treatment of acute... Via Benzinga Exposures Product Safety 20 Stocks Moving in Friday's Pre-Market Session July 30, 2021 Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 50.9% to $6.20 in pre-market trading after the company announced its eryaspase was granted U.S. FDA Fast Track designation... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Thursday's After-Market Session July 29, 2021 Gainers Erytech Pharma (NASDAQ:ERYP) sha... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 29, 2021 Gainers NanoVibronix (NASDAQ:NAOV) share... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session July 28, 2021 Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 40.13% to $2.13 during Wednesday's pre-market session. The company's market cap stands at $... Via Benzinga Mid-Afternoon Market Update: Dow Rises 50 Points; Iterum Therapeutics Shares Slide July 26, 2021 Toward the end of trading Monday, the Dow traded up 0.15% to 35,112.39 while the NASDAQ fell 0.10% to 14,822.88. The S&P also rose, gaining 0.09% to 4,415.85. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Intraday Session July 26, 2021 Gainers Tyme Technologies (NASDAQ:TYME) shares rose 77.31% to $1.92 during Monday's regular session. Tyme Technologies's stock is trading at a volume of 215.0... Via Benzinga 74 Biggest Movers From Yesterday July 27, 2021 Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 109.7% to close at $8.87 on Monday after the company announced it entered into a second strategic co-mining agreement with... Via Benzinga Mid-Day Market Update: Crude Oil Down 1%; Xenetic Biosciences Shares Spike Higher July 26, 2021 Midway through trading Monday, the Dow traded down 0.19% to 34,996.16 while the NASDAQ fell 0.07% to 14,827.27. The S&P also fell, dropping 0.08% to 4,408.04. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 48 Stocks Moving In Monday's Mid-Day Session July 26, 2021 Gainers Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session July 26, 2021 Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million.... Via Benzinga Iterum Therapeutics Stock Plunges After FDA Rejects Its Sulopenem Application July 26, 2021 Iterum Therapeutics plc (NASDAQ: ITRM) has received a Complete Response Letter (CRL) from the FDA regarding its marketing application seeking approval for... Via Benzinga Exposures Product Safety 40 Stocks Moving in Monday's Pre-Market Session July 26, 2021 Gainers Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday. NanoVibronix Inc (NASDAQ: NAOV) shares rose 45.2... Via Benzinga The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs, And More July 25, 2021 Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefited from the optimism that was set in motion by the solid start to the pharma reporting... Via Talk Markets Exposures Product Safety 12 Health Care Stocks Moving In Friday's Intraday Session July 09, 2021 Gainers Galectin Therapeutics (NASDAQ:GALT) shares moved upwards by 35.0% to $3.73 during Friday's regular session. As of 12:30 EST, Galectin Therapeutics's stock... Via Benzinga The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More July 25, 2021 Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... Via Benzinga Exposures Product Safety Iterum Therapeutics Analyst Remains Bullish Despite Concerns Over FDA Letter July 02, 2021 A lack of clarity and final decision in the U.S. Food and Drug Administration's (FDA) recent letter to Iterum Therapeutics PLC&nbs... Via Benzinga Exposures Product Safety 56 Biggest Movers From Friday July 06, 2021 Gainers Sequential Brands Group, Inc. (NASDAQ: SQBG) jumped 89.2% to settle at $15.70. Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 73.2% to close at $18.79. A 13G... Via Benzinga Mid-Afternoon Market Update: Silver Rises 2%; Alector Shares Spike Higher July 02, 2021 Toward the end of trading Friday, the Dow traded up 0.46% to 34,792.90 while the NASDAQ rose 0.67% to 14,619.12. The S&P also rose, gaining 0.66% to 4,348.47. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Friday's Intraday Session July 02, 2021 Gainers Alector (NASDAQ:ALEC) shares moved upwards by 52.47% to $34.17 during Friday's regular session. Alector's stock is trading at a volume of 26.9 million... Via Benzinga Mid-Day Market Update: Dow Surges Over 100 Points; Arrowhead Pharmaceuticals Shares Plummet July 02, 2021 Midway through trading Friday, the Dow traded up 0.33% to 34,747.45 while the NASDAQ rose 0.50% to 14,594.85. The S&P also rose, gaining 0.47% to 4,340.12. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities Why Iterum Therapeutics Stock Is Crashing Today July 02, 2021 The company received disappointing news from the FDA. Via The Motley Fool Exposures Product Safety 12 Health Care Stocks Moving In Friday's Pre-Market Session July 02, 2021 Gainers Alector (NASDAQ:ALEC) stock moved upwards by 39.93% to $31.36 during Friday's pre-market session. The market value of their outstanding shares is at $2.5... Via Benzinga The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures July 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc... Via Benzinga Iterum Stock Nose Dives As FDA Flags Deficiencies In Sulopenem Application July 02, 2021 Iterum Therapeutics plc (NASDAQ: ITRM) has received a letter from the FDA regarding the sulopenem etzadroxil/probenecid marketing application review for... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.